<figure><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iljYjdJF56lM/v4/-1x-1.jpg"><figcaption><div><p>Source: Bloomberg, 34:48</p></div><div></div></figcaption></figure><p>Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the FDA approval of a third Covid vaccine shot for people with weak immune systems. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Health Care Reporter Cynthia Koons discuss Cynthia&apos;s Businessweek Magazine story Don&#x2019;t Lose Sight of Fact That Covid Vaccines Are Working. Bloomberg Opinion Healthcare Columnist Max Nisen discusses the &quot;Tesla-fication&quot;of Moderna. And we Drive to the Close with Rebecca Corbin, CEO of Corbin Advisors. </p><p>Host: Carol Massar. Producer: Paul Brennan.</p>

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the FDA approval of a third Covid vaccine shot for people with weak immune systems. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Health Care Reporter Cynthia Koons discuss Cynthia's Businessweek Magazine story Don’t Lose Sight of Fact That Covid Vaccines Are Working. Bloomberg Opinion Healthcare Columnist Max Nisen discusses the "Tesla-fication"of Moderna. And we Drive to the Close with Rebecca Corbin, CEO of Corbin Advisors. 
Host: Carol Massar. Producer: Paul Brennan.


FDA Clears Shot for Some With Poor Immune Defence

Editorials and commentaries from Bloomberg Opinion